Cargando…
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627973/ https://www.ncbi.nlm.nih.gov/pubmed/37855895 http://dx.doi.org/10.1007/s00401-023-02642-5 |
| _version_ | 1785131649404502016 |
|---|---|
| author | Maas, Sybren L. N. Sievers, Philipp Weber, Damien C. Weller, Michael van den Bent, Martin J. Mair, Maximilian J. Kros, Johan M. Carparrotti, Fransesca von Deimling, Andreas Salvador, Villà Freixa Peerdeman, Saskia Marguerite Casas-Martin, Jose Gorlia, Thierry Sahm, Felix Preusser, Matthias |
| author_facet | Maas, Sybren L. N. Sievers, Philipp Weber, Damien C. Weller, Michael van den Bent, Martin J. Mair, Maximilian J. Kros, Johan M. Carparrotti, Fransesca von Deimling, Andreas Salvador, Villà Freixa Peerdeman, Saskia Marguerite Casas-Martin, Jose Gorlia, Thierry Sahm, Felix Preusser, Matthias |
| author_sort | Maas, Sybren L. N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10627973 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106279732023-11-08 Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042 Maas, Sybren L. N. Sievers, Philipp Weber, Damien C. Weller, Michael van den Bent, Martin J. Mair, Maximilian J. Kros, Johan M. Carparrotti, Fransesca von Deimling, Andreas Salvador, Villà Freixa Peerdeman, Saskia Marguerite Casas-Martin, Jose Gorlia, Thierry Sahm, Felix Preusser, Matthias Acta Neuropathol Correspondence Springer Berlin Heidelberg 2023-10-19 2023 /pmc/articles/PMC10627973/ /pubmed/37855895 http://dx.doi.org/10.1007/s00401-023-02642-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Maas, Sybren L. N. Sievers, Philipp Weber, Damien C. Weller, Michael van den Bent, Martin J. Mair, Maximilian J. Kros, Johan M. Carparrotti, Fransesca von Deimling, Andreas Salvador, Villà Freixa Peerdeman, Saskia Marguerite Casas-Martin, Jose Gorlia, Thierry Sahm, Felix Preusser, Matthias Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042 |
| title | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042 |
| title_full | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042 |
| title_fullStr | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042 |
| title_full_unstemmed | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042 |
| title_short | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042 |
| title_sort | independent prognostic impact of dna methylation class and chromosome 1p loss in who grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of eortc 22042–26042 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627973/ https://www.ncbi.nlm.nih.gov/pubmed/37855895 http://dx.doi.org/10.1007/s00401-023-02642-5 |
| work_keys_str_mv | AT maassybrenln independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT sieversphilipp independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT weberdamienc independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT wellermichael independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT vandenbentmartinj independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT mairmaximilianj independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT krosjohanm independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT carparrottifransesca independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT vondeimlingandreas independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT salvadorvillafreixa independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT peerdemansaskiamarguerite independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT casasmartinjose independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT gorliathierry independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT sahmfelix independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 AT preussermatthias independentprognosticimpactofdnamethylationclassandchromosome1plossinwhograde2and3meningiomaundergoingadjuvanthighdoseradiotherapycomprehensivemolecularanalysisofeortc2204226042 |